Today, asthma and COPD affect more than 550 million people worldwide, representing a huge and growing burden on patients, healthcare systems, and the planet. In an interview with EMJ, chronic respiratory disease specialists Simon Couillard, Professor at the University of Sherbrooke, Canada; Richard Russell, Professor at King’s College London, UK; and Arzu Yorgancioglu, Professor at Celal Bayar University, Manisa, Turkey, provide unique insights into the benefits of early intervention for asthma and COPD on both patient outcomes and the environment.
In this issue
Rate this content's potential impact on patient outcomes
Thank you!
Please share some more information on the rating you have given